Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

61.73

+0.50 (0.82%)

as of Aug 14, 2026, 8:00:00 pm Market Open.

1631 watching

Investor Insights

Aug 15, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered a mixed but generally positive outlook from a variety of analysts. The company has shown solid growth, particularly in Asia, where it is capitalizing on opportunities in wealth management and life insurance. Despite recent reports suggesting higher valuations, some experts caution that the current price might be overbought, and they advise being selective in the financials sector. Analysts note that while MFC faces challenges from a new tax in China and a dip in US operations, its robust dividend yield and consistent performance make it a reliable long-term hold. Overall, many recommend waiting for potential pullbacks before increasing positions, highlighting MFC's potential for sustained growth amidst the competitive landscape of Canadian financials.

Consensus

Positive

Valuation

Fair Value

Similar

SLF

DON'T BUY

Stock has been struggling for the last little while. Resistance at current levels. Out of the period of seasonal strength. Between Oct and Jan is it’s strong time. Different than banks, which are Feb to May. Stay away for now.

WEAK BUY

Their exposure to Japan shouldn’t be much. In the short term, he prefers banks over life companies.

PAST TOP PICK

(Top Pick Apr. 19/10, Down 7.21%) Well-known story, has recovered somewhat, but pulled back very recently. Unhedged to the market and had a billion and a half of product that they had to guarantee. In 12 to 18 months you might see a dividend increase. They have covered the hedge to more than half of where it was.

DON'T BUY

In the event of a market correction, they might benefit because of all the hedging they have done. To him, a permanent marker against them is their error in writing unhedged insurance premiums.

HOLD

Historically they have taken too much risk and not hedged enough on their balance sheet. If you have a 2-year horizon, this is a good entry point.

DON'T BUY

Doesn’t own their equities but does own their bonds. Not his favourite name. Quite a valuation discount compared to other Cdn lifecos. Management track record is not as good as others so valuation difference is warranted.

BUY

Doesn’t expect they will raise dividends, as they are worried about battening down the hatches. Were very exposed to the equity and bond markets but are less vulnerable now. They are hoping for a 32% ROE. Great assets in Asia, which will be their growth profile. Mid $20’s in the next year or two would be appropriate.

HOLD

Has recovered off the bottom quite nicely. They are definitely de-risking their business. Have to get back to operating their core operations of insurance and wealth management. Will get a higher multiple with more stable earnings. Good long-term hold.

BUY

Benefiting from 3 things. 1) as bond yields go up insurance companies make more money 2) took a huge hit from their stock market exposure and as the market goes up they can unwind those losses and 3) their life insurance business continues to grow in Asia.

WAIT

Resistance at mid ’09 level, which we are almost at. He would rather pay more and have it break above.

BUY

With the stock market and bond yields going up, the stock price is going up. In terms of valuation, if you take out their Asian life insurance business, you get the North American business for free. Looks like it is recovering and you get a 2.7% yield while you wait.

SELL

Because of the derivatives they’ve created, it is highly leveraged to the stock market. If the market heads down this will have extra leverage to the downside. If you own, consider taking profits now.

COMMENT

Reporting Feb 14th. Stock has had a good bounce. Did a big acquisition in the US. Got really clobbered when they tied their success to equity markets but have now hedged. The question now is have they hedged away the rebound. It’ll take another couple of quarters to know. (Prefers Great West (GWO-T) through Power Financial (PWF-T).)

WAIT

Drop in later half of year was quite dramatic. The recovery is quite good now. Growth in Asia will add to bottom line. Things are stabilizing. There is a wait and see attitude. Get out below $17, could go up a dollar from here to $19.

HOLD

Was stopped out of this some time ago and has not got back in. Currently doing a $5 billion hedging program. Neutral on this but not interested in owning it here.

Showing 1,336 to 1,350 of 2,284 entries

Most Recent Experts

Bill Baruch, Founder, Blue Line Capital

Blue Line Capital

Richard Orrell

RN Croft Financial Group

Stan Wong

Private Wealth Management, ScotiaMcleod

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)